GV-971相关论文
A 36-week multicenter,randomized,double-blind,placebo-controlled,parallel-group,Phase 3 clinical tri
BACKGROUND New therapies are urgently needed for Alzheimer disease(AD).Sodium oligomannate(GV-971)is a marine-derive......
A 36-week multicenter, randomized, double-blind, placebo-controlled,parallel-group, Phase 3 clinical
BACKGROUND New therapies are urgently needed for Alzheimer disease(AD). Sodium oligomannate(GV-971) is a marine-derived ......
阿尔茨海默病患的福音!2019年11月2日,国度药品监视治理局核准了上海绿谷制药有限公司治疗阿尔茨海默病新药——甘露特钠胶囊(商品......
